Media Kit

[heading]Press Releases[/heading] [column size=”1-3″ last=”0″] [document file=”http://tiap.ca/wp-content/uploads/2016/03/ScarX-Therapeutics-Series-A-FINAL.pdf” width=”200″ height=””] [spacer size=”20″]

ScarX Therapeutics closes $2 million Series A financing

[/column] [column size=”1-3″ last=”0″] [document file=”http://tiap.ca/wp-content/uploads/2016/03/Accel-RX-FINAL.pdf” width=”200″ height=””] [spacer size=”20″]

AccelRx/BDC make second portfolio investment in ScarX Therapeutics

[/column] [column size=”1-3″ last=”1″] [document file=”http://tiap.ca/wp-content/uploads/2016/03/OCE-MScPoP-final-Feb-2016.pdf” width=”200″ height=””] [spacer size=”20″]

Ontario advancing nine medical research projects in cancer, heart disease and sleep apnea to market

[/column] [column size=”1-3″ last=”0″] [document file=”http://tiap.ca/wp-content/uploads/2016/03/Zucara-FInal.pdf” width=”200″ height=””] [spacer size=”20″]

Zucara Therapeutics Inc. developing drug to prevent hypoglycemic episodes for people with diabetes

[/column] [column size=”1-3″ last=”0″][/column] [column size=”1-3″ last=”1″][/column] [spacer size=”20″] [heading]Corporate[/heading] [column size=”1-3″ last=”0″] [document file=”http://tiap.ca/wp-content/uploads/2016/03/MI_Jan2016_OnePager.pdf” width=”200″ height=””] [spacer size=”20″]

About MaRS Innovation

[/column] [column size=”1-3″ last=”0″][/column] [column size=”1-3″ last=”1″][/column] [spacer size=”20″] [heading]Logos[/heading] [column size=”1-3″ last=”0″][/column] [column size=”1-3″ last=”0″][/column] [column size=”1-3″ last=”1″][/column] [spacer size=”20″] [heading]Our Experts[/heading]